Cargando…

Nanostructured lipid carriers for incorporation of copper(II) complexes to be used against Mycobacterium tuberculosis

Tuberculosis (TB) is a disease caused by Mycobacterium tuberculosis. Cessation of treatment before the recommended conclusion may lead to the emergence of multidrug-resistant strains. The aim of this study was to develop nanostructured lipid carriers (NLCs) for use in the treatment of M. tuberculosi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sato, Mariana R, Oshiro Junior, João A, Machado, Rachel TA, de Souza, Paula C, Campos, Débora L, Pavan, Fernando R, da Silva, Patricia B, Chorilli, Marlus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367736/ https://www.ncbi.nlm.nih.gov/pubmed/28356717 http://dx.doi.org/10.2147/DDDT.S127048

Ejemplares similares

Enhancing Antifungal Treatment of Candida albicans with Hypericin-Loaded Nanostructured Lipid Carriers in Hydrogels: Characterization, In Vitro, and In Vivo Photodynamic Evaluation
por: Sato, Mariana Rillo, et al.
Publicado: (2023)

In Vitro Activity of Copper(II) Complexes, Loaded or Unloaded into a Nanostructured Lipid System, against Mycobacterium tuberculosis
por: da Silva, Patricia B., et al.
Publicado: (2016)

A Nanostructured Lipid System as a Strategy to Improve the in Vitro Antibacterial Activity of Copper(II) Complexes
por: da Silva, Patricia B., et al.
Publicado: (2015)

Characterization and toxicity of citral incorporated with nanostructured lipid carrier
por: Nordin, Noraini, et al.
Publicado: (2018)

A Nanostructured Lipid System to Improve the Oral Bioavailability of Ruthenium(II) Complexes for the Treatment of Infections Caused by Mycobacterium tuberculosis
por: da Silva, Patricia B., et al.
Publicado: (2018)

Corrigendum: A Nanostructured Lipid System to Improve the Oral Bioavailability of Ruthenium(II) Complexes for the Treatment of Infections Caused by Mycobacterium tuberculosis
por: da Silva, Patricia B., et al.
Publicado: (2019)

Corrigendum: A Nanostructured Lipid System to Improve the Oral Bioavailability of Ruthenium(II) Complexes for the Treatment of Infections Caused by Mycobacterium tuberculosis
por: da Silva, Patricia B., et al.
Publicado: (2019)

Solid Lipid Nanoparticles vs. Nanostructured Lipid Carriers: A Comparative Review
por: Viegas, Cláudia, et al.
Publicado: (2023)

Nanostructured Lipid Systems as a Strategy to Improve the in Vitro Cytotoxicity of Ruthenium(II) Compounds
por: de Freitas, Eduardo Sinesio, et al.
Publicado: (2014)

Nanostructured lipid system as a strategy to improve the anti-Candida albicans activity of Astronium sp.
por: Bonifácio, Bruna Vidal, et al.
Publicado: (2015)

Ciprofloxacin Loaded Nanostructured Lipid Carriers Incorporated into In-Situ Gels to Improve Management of Bacterial Endophthalmitis
por: Youssef, Ahmed, et al.
Publicado: (2020)

Antineoplastics Encapsulated in Nanostructured Lipid Carriers
por: Rodrigues da Silva, Gustavo Henrique, et al.
Publicado: (2021)

Nanostructured Lipid Carriers Aimed to the Ocular Delivery of Mangiferin: In Vitro Evidence
por: Santonocito, Debora, et al.
Publicado: (2023)

Nanostructured lipid carriers loaded with resveratrol modulate human dendritic cells
por: Barbosa, João P, et al.
Publicado: (2016)

Incorporation of Nonyl 3,4-Dihydroxybenzoate Into Nanostructured Lipid Systems: Effective Alternative for Maintaining Anti-Dermatophytic and Antibiofilm Activities and Reducing Toxicity at High Concentrations
por: Costa-Orlandi, Caroline Barcelos, et al.
Publicado: (2020)

Development of a Mosquito Repellent Formulation Based on Nanostructured Lipid Carriers
por: Abrantes, Daniele Carvalho, et al.
Publicado: (2021)

Riluzole-Loaded Nanostructured Lipid Carriers for Hyperproliferative Skin Diseases
por: Llorente, Xavier, et al.
Publicado: (2023)

Alkyl Protocatechuate-Loaded Nanostructured Lipid Systems as a Treatment Strategy for Paracoccidioides brasiliensis and Paracoccidioides lutzii In Vitro
por: Medina-Alarcón, Kaila P., et al.
Publicado: (2017)

Nanostructured Lipid Carriers: A potential drug carrier for cancer chemotherapy
por: Selvamuthukumar, Subramanian, et al.
Publicado: (2012)

Improvement of fluvastatin bioavailability by loading on nanostructured lipid carriers
por: El-Helw, Abdel-Rahim M, et al.
Publicado: (2015)

Nanostructured lipid carriers: versatile oral delivery vehicle
por: Poonia, Neelam, et al.
Publicado: (2016)

Oral Bioavailability Enhancement of Raloxifene with Nanostructured Lipid Carriers
por: Murthy, Aditya, et al.
Publicado: (2020)

Biodistribution of Nanostructured Lipid Carriers in Mice Atherosclerotic Model
por: Devel, Laurent, et al.
Publicado: (2019)

Nanostructured Lipid Carriers for Delivery of Chemotherapeutics: A Review
por: Haider, Mohamed, et al.
Publicado: (2020)

Nanostructured Lipid Carriers Loaded with Baicalin: An Efficient Carrier for Enhanced Antidiabetic Effects
por: Shi, Feng, et al.
Publicado: (2016)

Ocular Formulation Based on Palmitoylethanolamide-Loaded Nanostructured Lipid Carriers: Technological and Pharmacological Profile
por: Puglia, Carmelo, et al.
Publicado: (2020)

Formulation and in vitro characterization of domperidone loaded solid lipid nanoparticles and nanostructured lipid carriers
por: Thatipamula, RP., et al.
Publicado: (2011)

In Vitro Studies on Nasal Formulations of Nanostructured Lipid Carriers (NLC) and Solid Lipid Nanoparticles (SLN)
por: Costa, Cláudia Pina, et al.
Publicado: (2021)

Improvement of citral antimicrobial activity by incorporation into nanostructured lipid carriers: a potential application in food stuffs as a natural preservative
por: Mokarizadeh, Manijeh, et al.
Publicado: (2017)

Primary Lung Dendritic Cell Cultures to Assess Efficacy of Spectinamide-1599 Against Intracellular Mycobacterium tuberculosis
por: Santos, Karen, et al.
Publicado: (2018)

Effect of compositions in nanostructured lipid carriers (NLC) on skin hydration and occlusion
por: Loo, CH, et al.
Publicado: (2013)

Enhancing Oral Bioavailability and Brain Biodistribution of Perillyl Alcohol Using Nanostructured Lipid Carriers
por: Peczek, Samila Horst, et al.
Publicado: (2023)

Combination of calcipotriol and methotrexate in nanostructured lipid carriers for topical delivery
por: Lin, Yin-Ku, et al.
Publicado: (2010)

Improvement of oral bioavailability of lovastatin by using nanostructured lipid carriers
por: Zhou, Jun, et al.
Publicado: (2015)

The Improvement of Skin Whitening of Phenylethyl Resorcinol by Nanostructured Lipid Carriers
por: Kim, Bo-Sik, et al.
Publicado: (2017)

Astaxanthin-Loaded Nanostructured Lipid Carriers for Preservation of Antioxidant Activity
por: Rodriguez-Ruiz, Violeta, et al.
Publicado: (2018)

Evaluation of Nanostructured Lipid Carriers Produced with Interesterified Buriti Oil
por: de Castro Reis, Lívia Viana, et al.
Publicado: (2020)

Structural Features and the Anti-Inflammatory Effect of Green Tea Extract-Loaded Liquid Crystalline Systems Intended for Skin Delivery
por: Bento da Silva, Patricia, et al.
Publicado: (2017)

Intranasal delivery of nanostructured lipid carriers, solid lipid nanoparticles and nanoemulsions: A current overview of in vivo studies
por: Costa, Cláudia Pina, et al.
Publicado: (2021)

Fungal diseases: could nanostructured drug delivery systems be a novel paradigm for therapy?
por: Voltan, Aline Raquel, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_m5ntucbup5pa7o8efct305l721